Catapult Sports (ASX: CAT) posts record 27-28% ACV growth in FY26 trading update as dual acquisitions reshape the sports analytics platform
Read More 2 minute read Pharma Industry News Immune-Onc Therapeutics gets FDA orphan drug status for IO-202 in CMML Immune-Onc Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapies in immunology and oncology,… byPallavi MadhirajuFebruary 22, 2024